Physician profile
Daniel M Stein
NPI 1841447513
$2,223.14
in general payments reported to CMS, 2019-2025
20 companies · $224 in 2025
The $224 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $133 · 2021: $285 · 2022: $393 · 2023: $577 · 2024: $279 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,080.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $638.21 | 2019-2025 | Titan, Speedicath |
| Astellas Pharma US INC | $498.15 | 2019-2023 | Myrbetriq |
| Boston Scientific Corporation | $196.68 | 2022-2025 | Spaceoar Vue System - 10ml, Lithovue, Lithoclast |
| Allergan, INC. | $141.32 | 2019-2021 | |
| Dornier Medtech America, INC | $133.54 | 2023 | Dornier Medtech |
| 180 Medical, INC. | $90.47 | 2025 | |
| Abbvie INC. | $88.35 | 2022-2025 | Botox |
| Procept Biorobotics Corporation | $64.98 | 2022-2025 | |
| Rochester Medical Corporation | $55.25 | 2019 | |
| Olympus America INC. | $50.37 | 2019-2024 | Uretero-Reno Videoscope |
| Ferring Pharmaceuticals INC. | $46.51 | 2024-2025 | Adstiladrin |
| Laborie Medical Technologies Corp. | $35.63 | 2023 | |
| Urogen Pharma, INC. | $33.96 | 2021-2025 | |
| Integra Lifesciences Corporation | $26.40 | 2021 | |
| Axonics, INC. | $24.95 | 2023 | Axonics |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $21.27 | 2023 | Orgovyx |
| Palette Life Sciences, INC. | $20.50 | 2022 | |
| Janssen Biotech, INC. | $19.82 | 2021 | |
| Myovant Sciences INC. | $18.77 | 2022 | |
| Hollister Incorporated | $18.01 | 2023 | Infyna Chic, Vapro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.